AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 279: E284-E292, 2000;
0193-1849/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, P.-S.
Right arrow Articles by Cherrington, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, P.-S.
Right arrow Articles by Cherrington, A. D.
Vol. 279, Issue 2, E284-E292, August 2000

Importance of the hepatic arterial glucose level in generation of the portal signal in conscious dogs

Po-Shiuan Hsieh1, Mary Courtney Moore1, Doss W. Neal2, and Alan D. Cherrington1,2

1 Department of Molecular Physiology and Biophysics, 2 Diabetes Research and Training Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

The aim of this study was to determine whether the elimination of the hepatic arterial-portal (A-P) venous glucose gradient would alter the effects of portal glucose delivery on hepatic or peripheral glucose uptake. Three groups of 42-h-fasted conscious dogs (n = 7/group) were studied. After a 40-min basal period, somatostatin was infused peripherally along with intraportal insulin (7.2 pmol·kg-1·min-1) and glucagon (0.65 ng·kg-1·min-1). In test period 1 (90 min), glucose was infused into a peripheral vein to double the hepatic glucose load (HGL) in all groups. In test period 2 (90 min) of the control group (CONT), saline was infused intraportally; in the other two groups, glucose was infused intraportally (22.2 µmol·kg-1·min-1). In the second group (PD), saline was simultaneously infused into the hepatic artery; in the third group (PD+HAD), glucose was infused into the hepatic artery to eliminate the negative hepatic A-P glucose gradient. HGL was twofold basal in each test period. Net hepatic glucose uptake (NHGU) was 10.1 ± 2.2 and 12.8 ± 2.1 vs. 11.5 ± 1.6 and 23.8 ± 3.3* vs. 9.0 ± 2.4 and 13.8 ± 4.2 µmol · kg-1·min-1 in the two periods of CONT, PD, and PD+HAD, respectively (* P < 0.05 vs. same test period in PD and PD+HAD). NHGU was 28.9 ± 1.2 and 39.5 ± 4.3 vs. 26.3 ± 3.7 and 24.5 ± 3.7* vs. 36.1 ± 3.8 and 53.3 ± 8.5 µmol·kg-1·min-1 in the first and second periods of CONT, PD, and PD+HAD, respectively (* P < 0.05 vs. same test period in PD and PD+HAD). Thus the increment in NHGU and decrement in extrahepatic glucose uptake caused by the portal signal were significantly reduced by hepatic arterial glucose infusion. These results suggest that the hepatic arterial glucose level plays an important role in generation of the effect of portal glucose delivery on glucose uptake by liver and muscle.

liver; liver nerve; hepatic glucose uptake


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Fukaya, A. Mizuno, H. Arai, K. Muto, T. Uebanso, K. Matsuo, H. Yamamoto, Y. Taketani, T. Doi, and E. Takeda
Mechanism of rapid-phase insulin response to elevation of portal glucose concentration
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E515 - E522.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. C. Moore, M. J. Burish, B. Farmer, D. W. Neal, C. Pan, and A. D. Cherrington
Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E845 - E853.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. Iozzo, F. Geisler, V. Oikonen, M. Maki, T. Takala, O. Solin, E. Ferrannini, J. Knuuti, and P. Nuutila
Insulin Stimulates Liver Glucose Uptake in Humans: An 18F-FDG PET Study
J. Nucl. Med., May 1, 2003; 44(5): 682 - 689.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Bajaj, R. Berria, T. Pratipanawatr, S. Kashyap, W. Pratipanawatr, R. Belfort, K. Cusi, L. Mandarino, and R. A. DeFronzo
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E346 - E352.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. K. Rayner, M. Samsom, K. L. Jones, and M. Horowitz
Relationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control
Diabetes Care, February 1, 2001; 24(2): 371 - 381.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online